Jinhe Biological Technology Co., Ltd. (Stock Code: 002688)
Announcement No.: 2026-018
The company and all members of the board guarantee that the content of this announcement is true, accurate, and complete, and bear responsibility for any false records, misleading statements, or significant omissions in the announcement.
I. Basic Information on Raised Funds
According to the approval document issued by the China Securities Regulatory Commission (CSRC) on December 4, 2020, regarding the non-public issuance of shares by Jinhe Biological Technology Co., Ltd. (CSRC Approval [2020] No. 3344), the company was authorized to issue 145,132,743 shares at a par value of RMB 1 per share, with an issue price of RMB 5.65 per share. The total amount of funds raised was RMB 819,999,997.95, and after deducting the non-taxable issuance costs of RMB 17,756,396.62, the net amount raised was RMB 802,243,601.33. The raised funds have been verified by Xinyong Zhonghe Accounting Firm (Special General Partnership), which issued Verification Report No. XYZH/2021XAAA50306 to confirm this.